Infliximab in the treatment of rheumatoid meningoencephalitis

J Neurol. 2009 Dec;256(12):2094-6. doi: 10.1007/s00415-009-5286-0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / immunology
  • Female
  • Humans
  • Immunosuppression Therapy / methods
  • Infliximab
  • Meningoencephalitis / drug therapy*
  • Meningoencephalitis / etiology*
  • Meningoencephalitis / immunology
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab